DAFNA Capital Management LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 2:35 pm Sale |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
DAFNA Capital Management LLC | 895,200 1.370% |
-215,849 (-19.43%) |
Filing |
| 2024-02-14 2:54 pm Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
DAFNA Capital Management LLC | 1,111,049 5.490% |
1,111,049 (New Position) |
Filing |